- Home
- / Epicrispr Biotechnologies
Epicrispr Biotechnologies
Total Funding
$55 M
Epicrispr Biotechnologies Summary
Company Summary
- Overview
- Epicrispr Biotechnologies is a biotechnology company that provides ultra-compact therapies for gene expression modulation in vivo. It develops GEMS (Gene Expression Modulation System) platform that enables to combine gene modulators to create customized therapies for specific disease indications.
- Type
- Private
- Status
- Active
- Founded
- 2018
- HQ
- San Francisco, CA, US | view all locations
- Website
- https://epicrispr.com/
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
San Francisco, CA HQ
United States
7000 Shoreline Court, Suite 100
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026